- Home
- AIRG vs TENX Comparison
AIRG vs TENX Comparison
Compare AIRG & TENX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | AIRG | TENX |
|---|---|---|
| Founded | 1995 | 1967 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Radio And Television Broadcasting And Communications Equipment | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 47.7M | 56.2M |
| IPO Year | 2016 | N/A |
Fundamental Metrics
Financial Performance| Metric | AIRG | TENX |
|---|---|---|
| Price | $3.98 | $9.80 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 3 | 2 |
| Target Price | $6.33 | ★ $17.00 |
| AVG Volume (30 Days) | 62.0K | ★ 116.3K |
| Earning Date | 11-12-2025 | 11-12-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $54,737,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $16.56 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $3.00 | $4.63 |
| 52 Week High | $9.12 | $9.91 |
Technical Indicators
Market Signals| Indicator | AIRG | TENX |
|---|---|---|
| Relative Strength Index (RSI) | 46.67 | 73.28 |
| Support Level | $3.90 | $8.76 |
| Resistance Level | $4.20 | $9.70 |
| Average True Range (ATR) | 0.29 | 0.55 |
| MACD | -0.01 | 0.13 |
| Stochastic Oscillator | 37.21 | 90.51 |
Price Performance
Historical ComparisonAbout AIRG Airgain Inc.
Airgain Inc is engaged in providing antenna technologies. These technologies can be used to enable performance wireless networking across devices and markets which include connected homes, enterprises, automotive, and the Internet of Things. It also provides solutions to complex radio frequency, engineering challenges, and improving wireless service that require higher throughput, broad coverage footprint, and carrier-grade quality. Geographically, it derives maximum revenue from North America and also has a presence in China and the Rest of the World. The company products include Antenna Plus: Fleet, M2M, IoT Antennas, Carrier-Class Antenna, Embedded Antennas, and External Dipole Antennas.
About TENX Tenax Therapeutics Inc.
Tenax Therapeutics Inc is a specialty pharmaceutical company focused on identifying, developing, and commercializing products that address cardiovascular and pulmonary diseases with high unmet medical needs. The company owns North American rights to develop and commercialize levosimendan and has released topline data regarding the Phase 2 clinical trial for the use of levosimendan in the treatment of pulmonary hypertension associated with Heart Failure and preserved Ejection Fraction.